Romosozumab treatment enhances BMD in men with osteoporosis


eMediNexus    11 July 2018

Romosozumab improves bone mineral density (BMD) in men with osteoporosis, according to results from the BRIDGE (placeBo-contRolled double-blind study evaluatIng the efficacy anD safety of romosozumab in treatinG mEn with osteoporosis) trial reported online June 20, 2018 in The Journal of Clinical Endocrinology and Metabolism. One year treatment with 210 mg SC QM romosozumab increased spine and hip BMD compared with placebo and was well tolerated.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.